This company has been marked as potentially delisted and may not be actively trading. NASDAQ:ITMR Itamar Medical (ITMR) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Itamar Medical Stock (NASDAQ:ITMR) 30 days 90 days 365 days Advanced Chart Get Itamar Medical alerts:Sign Up Key Stats Today's Range$30.87▼$30.8750-Day Range$30.54▼$30.8752-Week Range$16.36▼$30.91VolumeN/AAverage Volume90,796 shsMarket Capitalization$497.25 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Itamar Medical Ltd. engages in the research, development, marketing, selling, and leasing of non-invasive medical devices based on peripheral arterial tone signals. It develops and markets two products, namely, WatchPAT and EndoPAT. The WatchPAT diagnoses sleep apnea, which has been proven to be a substantial risk factor in cardiac disease. The EndoPAT diagnoses endothelial malfunction, which is a proven predictor of cardiovascular disease. The company was founded by Yaron Giora , Martin Gerstel, Peretz Lavie, and Daniel Gur on January 15, 1997 and is headquartered in Caesarea, Israel. Read More Receive ITMR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Itamar Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address ITMR Stock News HeadlinesNational Security Minister Itamar Ben Gvir's daughter out of hospital following accidentApril 27, 2024 | msn.comITMR Historical DataOctober 17, 2023 | investing.comBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most investors are still asleep… but not for long. Garrett Goggin’s latest research reveals how you can “front-run” the greatest investor alive by positioning in four small miners sitting on up to 100X potential upside. When this hits the news — it’ll be too late. | Golden Portfolio (Ad)Read Your Way Around the WorldAugust 3, 2023 | nytimes.comFind the Best Medical SchoolsMay 14, 2023 | usnews.comSarit Packer and Itamar SrulovichSeptember 24, 2022 | bbc.co.ukZOLL Announces Closing of Acquisition of Itamar MedicalDecember 16, 2021 | finance.yahoo.comItamar Medical Ltd. Sponsored ADR (ITMR) Reports Q3 Loss, Lags Revenue EstimatesNovember 18, 2021 | finance.yahoo.comSee More Headlines ITMR Stock Analysis - Frequently Asked Questions How were Itamar Medical's earnings last quarter? Itamar Medical Ltd. (NASDAQ:ITMR) posted its quarterly earnings results on Thursday, November, 18th. The company reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.17) by $0.32. The company had revenue of $13.57 million for the quarter, compared to the consensus estimate of $13.70 million. Does Itamar Medical have any subsidiaries? Itamar Medical subsidiaries include these companies: I.M.E. 2016 B.V., Itamar Medical Inc., and Itamar Medical Japan Co. Ltd.. What other stocks do shareholders of Itamar Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Itamar Medical investors own include AbbVie (ABBV), Avino Silver & Gold Mines (ASM), Gilead Sciences (GILD), Cheniere Energy (LNG), M&T Bank (MTB), Energy Transfer (ET) and International Business Machines (IBM). Company Calendar Last Earnings11/18/2021Today7/03/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:ITMR CIK1613170 Webwww.itamar-medical.com Phone(724) 617-7000FaxN/AEmployees257Year Founded1997Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$41.03 million Price / Sales12.12 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares16,108,000Free FloatN/AMarket Cap$497.25 million OptionableNot Optionable Beta0.73 Social Links A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (NASDAQ:ITMR) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Itamar Medical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Itamar Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.